Skip to main content
. 2020 May 5;2020:6012102. doi: 10.1155/2020/6012102

Figure 1.

Figure 1

Comparison of raw circulating levels of MMP-1 across individuals diagnosed with benign prostate hyperplasia (BPH) or prostate cancer (PCa). Significance was verified by the partial correlation test controlled for all three rs495366 genotypes. Vertical bars represent intervals of one standard error. #The effect size (d) is 1.57, and 95% confidence interval is (0.3; 0.6) for BPH and (0.5; 1.4) for PCa.